CCT7 Expression Affects the Prognosis of Lung Adenocarcinoma
Cancer Reports · 2026-07 · 9 (7)
DOI: 10.1002/cnr2.70610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 29.06.2026. Verfasst von Yue Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Biomarkers, Tumor, Chaperonin Containing TCP-1. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Clinical Specialty Construction Project, Guangxi Medical and Health Key Discipline Construction Project, Guangxi Key Clinical Specialty Construction Project.
Abstract (Originalsprache)
Background
CCT7 is a chaperonin containing tailless complex polypeptide 1 subunit. The study focused on investigating its prognostic significance for lung adenocarcinoma (LUAD).
Methods
CCT7 expression in LUAD and matched non‐carcinoma lung samples was examined via TCGA database. Besides, we utilized the GEO database and RT‐qPCR for validating differential CCT7 expression. The relation with clinical factors and its functions in diagnosis and prognosis prediction were determined. GO, KEGG, along with GSEA were conducted for exploring CCT7's functions. We also performed CIBERSORT, ssGSEA, and ESTIMATE for examining the LUAD immune microenvironment. By analyzing tumor mutational burden (TMB) and immune checkpoints, the relationship between CCT7 and immunotherapy was explored.
Results
CCT7 expression significantly increased within LUAD relative to matched non‐carcinoma lung samples. As revealed by GO, KEGG, as well as GSEA results, CCT7 was mostly related to cell movement and regulation of multiple biological processes. Furthermore, CCT7 expression varied significantly among different immune cells, and those having increased CCT7 expression showed greater TMB.
Conclusions
An increase in CCT7 expression carries significant implications for diagnosing and predicting LUAD prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- Department of Anesthesiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
ORCID-Profile: Yue Li, Nuo Yang, Huafu Zhou
Förderung
- National Key Clinical Specialty Construction Project
- Guangxi Medical and Health Key Discipline Construction Project
- Guangxi Key Clinical Specialty Construction Project
Zitieren
APA
Li, Y., Wei, L., Feng, G., Li, G., Ma, J., Gao, X., Liu, J., Yang, N., & Zhou, H. (2026). CCT7 Expression Affects the Prognosis of Lung Adenocarcinoma. Cancer Reports, 9(7). https://doi.org/10.1002/cnr2.70610
Vancouver
Li Y, Wei L, Feng G, Li G, Ma J, Gao X, et al. CCT7 Expression Affects the Prognosis of Lung Adenocarcinoma. Cancer Reports. 2026;9(7). doi:10.1002/cnr2.70610
BibTeX
@article{Li2026,
author = {Li, Yue and Wei, Longqian and Feng, Guiyu and Li, Guosheng and Ma, Jielin and Gao, Xiang and Liu, Jun and Yang, Nuo and Zhou, Huafu},
title = {CCT7 Expression Affects the Prognosis of Lung Adenocarcinoma},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {7},
doi = {10.1002/cnr2.70610}
}
EUVIMED